Gu, F., Yuan, S., Liu, L., Zhu, P., Yang, Y., Pan, Z., & Zhou, W. (2019). EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis. J Cell Mol Med.
शिकागो स्टाइल उद्धरणGu, Fangming, Shengxian Yuan, Lei Liu, Peng Zhu, Yuan Yang, Zeya Pan, और Weiping Zhou. "EYA4 Serves As a Prognostic Biomarker in Hepatocellular Carcinoma and Suppresses Tumour Angiogenesis and Metastasis." J Cell Mol Med 2019.
एमएलए उद्धरणGu, Fangming, et al. "EYA4 Serves As a Prognostic Biomarker in Hepatocellular Carcinoma and Suppresses Tumour Angiogenesis and Metastasis." J Cell Mol Med 2019.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.